Johnson & Johnson (JNJ)
Available from the Temper Enrollment Service: Yes
Order DRIP EnrollmentLast Update On: 03/08/2010:
JNJ derives about half of its annual sales from foreign sources and 11.9% of 2008’s sales were devoted to R&D. The company has a strong balance sheet and net profit margins have averaged close to 18% over the last 10 years. Dividends have been increased annually for 47 straight years, with the latest increase bringing the payout to $1.96 per share, up from 1999’s payout of 55¢. Sales topped $61 billion in 2009, up from $27.5 billion in 1999. With $14.1 billion in cash assets, and a total debt load of only $11.6 billion, JNJ is in excellent financial shape. It has a 14% debt-to-capitalization ratio. Officers and directors own 5.3% and Berkshire owns 36.9 million of the 2.759 billion outstanding shares.
| Industry: | Health care & consumer products |
| Minimum Investment: | $25.00 |
| Maximum Investment: | 50,000/year |
| Shares to qualify: | 1 |
| Recent Price: | 57.83 |
| Investing Fee: | Co. pays fee |
| Fee for Dividends: | Co. pays fee |
Fee Information
For more detailed information on this company's DRIP, login or click here to subscribe.
You may also sign up for a free guest pass here to view this company's detailed information.
Information is based on an annual survey and updated when company changes become available.
